Navigation Links
ETHEX Corporation Voluntarily Recalls Three Lots of Dextroamphetamine Sulfate 5mg Tablets Due to the Potential for Oversized Tablets
Date:10/15/2008

Lot Number 77946, 81141 and 81142 NDC #58177-311-04

ST. LOUIS, Oct. 15 /PRNewswire/ -- ETHEX Corporation announced today that it has voluntarily recalled three specific lots (77946, 81141 and 81142) of Dextroamphetamine Sulfate 5 mg tablets, as a precaution, due to the possible presence of oversized tablets. Oversized tablets may contain as much as about twice the labeled amount of the active ingredient. The recalled lots were distributed by ETHEX Corporation under an "ETHEX" label between January 2007 and May 2008. The 5 mg product is an orange round tablet debossed with "ETHEX" and "311" on one side.

If someone were to take a higher than expected dose of Dextroamphetamine Sulfate, then the risk of adverse effects known to be associated with the drug such as tachycardia, hypertension, tremors, decreased appetite, headache, insomnia, dizziness, blurred vision, stomach upset, and dry mouth may be increased.

No report of any oversized Dextroamphetamine Sulfate tablets has been received by ETHEX from any wholesaler, retailer, consumer or caregiver, and ETHEX has not received any report of unexpected side effects or injury related to this product.

ETHEX Corporation is conducting this precautionary, voluntary recall because it found a small number of oversized tablets in lots which had not yet been distributed. These oversized tablets were removed before the lots were distributed.

Please be aware that there are multiple companies in the United States producing and marketing generic versions of Dextroamphetamine Sulfate 5 mg tablets and consumers and their caregivers are encouraged to check their prescriptions to determine the source of their tablets.

Any customer inquiries related to this action should be addressed to ETHEX Customer Service at 1-800-321-1705, or fax to ETHEX Customer Service at 314-646-3751 or sent via email to: customer-service@ethex.com with representatives
'/>"/>

SOURCE ETHEX Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. ETHEX Corporation Voluntarily Recalls a Single Lot of Morphine Sulfate 60 mg Extended Release Tablets Due to the Potential for Oversized Tablets
2. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
3. Brooke Franchise Corporation Announces Selected July Results
4. MedThink Communications Retained by NanoBio Corporation
5. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
6. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
7. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
8. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
9. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
10. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
11. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2010)... HealthDay Reporter , , THURSDAY, July 29 (HealthDay News) -- ... a better predictor of how well a woman will ... been the traditional way of looking at cancers, new ... the genetic makeup of 595 breast cancer tumors and ... used algorithms to separate the tumors into eight types ...
(Date:7/29/2010)... Administration (FDA) received reports of malignancies in children using ... an associated risk and prompting an investigation. Researchers from ... malignancy in children using infliximab, etanercept, and adalimumab and ... Arthritis & Rheumatism , a journal of the ... approved 3 TNF blockers for use in children: Etanercept ...
(Date:7/29/2010)... , , THURSDAY, July 29 (HealthDay News) -- New research ... the risk of broken bones in postmenopausal women with ... risk seen among men who had been prescribed either ... isn,t the first time such an association has been ... belong to the class of medications known as thiazolidinediones ...
(Date:7/29/2010)... history of male breast cancer perceive themselves to be at ... a family history of female breast cancer; however those with ... know about or seek genetic testing than those with a ... led by researchers at the University of Louisville,s James Graham ... accounts for only about one percent of all breast cancers, ...
(Date:7/29/2010)... new study from Perth,s Telethon Institute for Child Health ... diet in adolescents. , The research findings have just ... Attention Disorders . , Leader of Nutrition studies at ... examined the dietary patterns of 1800 adolescents from the ... ,Western, patterns. , "We found a diet high ...
Breaking Medicine News(10 mins):Health News:Breast Cancer's DNA Yields More Secrets 2Health News:Breast Cancer's DNA Yields More Secrets 3Health News:TNF blockers may increase the risk of malignancy in children 2Health News:TNF blockers may increase the risk of malignancy in children 3Health News:New Data Supports Link Between Diabetes Drugs, Fractures 2Health News:New Data Supports Link Between Diabetes Drugs, Fractures 3Health News:Male breast cancer in family leads to high perception of risk, low likelihood of genetic counseling 2Health News:Male breast cancer in family leads to high perception of risk, low likelihood of genetic counseling 3Health News:Western diet link to ADHD 2
... June 15, 2006 issue of CANCER, a peer-reviewed journal ... radiation// could be a treatment option for men aged ... ,Age has remained a controversial factor, which dictates ... recommend more aggressive therapy as compared to older individuals. ...
... is a generally accepted fact that the doses given ... it is not always clear, how much is enough ... Children’s Center shows that making the dosage a computerized ... well. ,An online infusion calculator and a ...
... leading cardinal has urged Christians to initiate legal action against ... he feels that it offends Christ// and the Church as ... it is enough for us to forgive and to forget,' ... attempts to disclose a murder mystery associated with the life ...
... remembered of the 90 million odd volunteers belonging to the ... back bone of the movement//, and whose helping hand is ... needy all over the world. , ,These unsung heroes ... risking their lives at times, in order to help others ...
... die every day in Madhya Pradesh due to pregnancy related complications, ... ,According to data from the National Family Health Survey (NFHS), the ... which means that out of every 100,000 women, 498 die either ... mother. ,Taking the Census figures, about 1.9 million ...
... apply for a separate insurance scheme as they would no ... may feel that they can go without insurance to save ... or diagnosed with a serious medical problem. Even those ... a few months since there's often a waiting period before ...
Other Medicine News:Health News:Dispensing Drug Dosage To Children Through Computers 2Health News:Dispensing Drug Dosage To Children Through Computers 3Health News:Dispensing Drug Dosage To Children Through Computers 4Health News:Salutations For The Selfless Heroes On World Red Cross Day 2Health News:At Least 25 Women Die Of Maternity Complications In MP Everyday 2Health News:Insurance Plans after Graduation 2
(Date:7/28/2010)... Matrixx Initiatives, Inc. (Nasdaq: MTXX ), an over-the-counter ... first quarter ended June 30, 2010 , will be released ... An earnings conference call will be held the following morning on ... . , , , ... access the teleconference, please call (888) 287-5536 (domestic) or (719) 325-2332 ...
(Date:7/28/2010)... DURECT Corporation (Nasdaq: DRRX ) announced today that ... Capital Markets 10th Annual Focus on Healthcare Conference on Thursday, August 5 ... at the Sheraton New York Hotel.   , ... (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO ) , , ... http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO ) , , , ...
(Date:7/28/2010)... , July 28 Dr. Michael Klein , ... how FDA works with other entities to confront and to prevent misuse ... , , ... , , ... , , ...
Breaking Medicine Technology:Matrixx Initiatives, Inc. Sets Time for Discussion of Fiscal 2011 First Quarter Financial Results 2DURECT to Present at the BMO Capital Markets Focus on Healthcare Conference 2FDA CONSUMER HEALTH INFORMATION - Combating Misuse and Abuse of Prescription Drugs: Q&A with Michael Klein, Ph.D. 2Information about the use and accuracy of breast cancer tests is lacking study finds 56994 1Information about the use and accuracy of breast cancer tests is lacking study finds 56994 2Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug Drug Interaction Profile for NKTR 118 4985 1Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug Drug Interaction Profile for NKTR 118 4985 2Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug Drug Interaction Profile for NKTR 118 4985 3Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug Drug Interaction Profile for NKTR 118 4985 4Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug Drug Interaction Profile for NKTR 118 4985 5Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug Drug Interaction Profile for NKTR 118 4985 6Two New Studies Report Increased Survival Rates in Tamiflu 28R 29 Treated Patients with Avian Flu 28H5N1 29 and Severe Seasonal Flu 4983 1Two New Studies Report Increased Survival Rates in Tamiflu 28R 29 Treated Patients with Avian Flu 28H5N1 29 and Severe Seasonal Flu 4983 2Two New Studies Report Increased Survival Rates in Tamiflu 28R 29 Treated Patients with Avian Flu 28H5N1 29 and Severe Seasonal Flu 4983 3Two New Studies Report Increased Survival Rates in Tamiflu 28R 29 Treated Patients with Avian Flu 28H5N1 29 and Severe Seasonal Flu 4983 4Two New Studies Report Increased Survival Rates in Tamiflu 28R 29 Treated Patients with Avian Flu 28H5N1 29 and Severe Seasonal Flu 4983 5
Eschenbach's new 2636 series of stand magnifiers delivers the benefits of high power and a large fields of view. Using a unique doublet lens design, the 2636 offers the highest power recatngular lens...
The Multi-Purpose Stand Magnifier is the most versatile stand magnifier. The stand has multiple configurations allowing for all situations where hands-free magnification is needed....
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
Bausch & Lomb round and rectangular magnifiers incorporate precision optics and an ergonomic design for increased clarity and comfort during use...
Medicine Products: